Psychotropic drug therapy and pharmaceutical industry
Modestin, J.
Arzneimittel-Forschung 20(7): 877-879
1970
ISSN/ISBN: 0004-4172 PMID: 5536047 Document Number: 30428
Document emailed within 1 workday
Related Documents
Robinson, D.S. 1994: Psychotropic drug labeling: regulatory, pharmaceutical industry, and clinical issues and perspectives. a pharmaceutical industry perspective on drug labeling Psychopharmacology Bulletin 30(1): 23-25Schacter, L.P.; Anderson, C.; Canetta, R.M.; Kelley, S.; Nicaise, C.; Onetto, N.; Rozencweig, M.; Smaldone, L.; Winograd, B. 1992: Drug discovery and development in the pharmaceutical industry Seminars in Oncology 19(6): 613-621
Personeus, G.R.; Ascione, P. 1981: Preparation and use of drug master files in the pharmaceutical industry Journal of Parenteral Science and Technology: a Publication of the Parenteral Drug Association 35(2): 63-69
Kopf, R. 1980: Drug legislation 1976: cost analysis for the pharmaceutical industry Der Internist 21(6): 333-338
Watkins, E.S. 2012: How the pill became a lifestyle drug: the pharmaceutical industry and birth control in the United States since 1960 American Journal of Public Health 102(8): 1462-1472
Matsumoto, T.; Kobayashi, O. 2010: Psycho-social therapy of disorders of psychotropic drug use: with special reference to cognitive behavior therapy to prevent repeated abuse Seishin Shinkeigaku Zasshi 112(7): 672-676
Lerch, C. 1994: Responsibility for patient education in drug therapy from the viewpoint of the drug industry Zeitschrift für Arztliche Fortbildung 88(12): 1055-1060
Smulevich, A.B.; Vorob'ev, V.I.; Tarasova, T.P.; Abrosimov, A.I. 1987: Psychotropic drug therapy using maintenance dosage pumps Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 87(6): 888-893
Iwahashi, K.; Fukamauchi, F.; Aoki, J.; Kurihara, K.; Yoshihara, E.; Inoue, M.; Shibanai, H.; Ishigooka, J. 2010: A daycare program of animal assisted therapy for affective disorder patients during psychotropic drug therapy: evaluation of the relaxation effect by fNIRS (functional near-infrared spectroscopy) Nihon Shinkei Seishin Yakurigaku Zasshi 30(3): 129-134
Schwarting, J.S. 2000: The pharmaceutical industry--to whom is it accountable? New England Journal of Medicine 343(19): 1416; Discussion 1417
Andersen, K. 1975: The responsibility of the pharmaceutical industry Nordisk Medicin 90(4): 115
Cohen, A.F. 2005: The pharmaceutical industry in uproar Nederlands Tijdschrift Voor Geneeskunde 149(19): 1074
Kahn, M.F. 1984: More on rheumatology and the pharmaceutical industry Journal of Rheumatology 11(5): 717-718
Aumonier, J. 2003: Action of the pharmaceutical industry Annales Pharmaceutiques Francaises 61(6): 378-382
Walker, A.M.; García Rodríguez, L.A.; Pérez Gutthann, S. 1992: Epidemiology and the pharmaceutical industry Medicina Clinica 98(12): 465-468
Rämsch, K.D. 1993: Experiences with GCP in the pharmaceutical industry [corrected Methods and Findings in Experimental and Clinical Pharmacology 15(4): 237-240
Hedner, T.; Thornblad, T.; Edgar, B.; Cowlrick, I.; Olausson, M.; Lind, L.; Klofsten, M. 2012: Major changes in the global pharmaceutical industry Lakartidningen 109(7): 324-325
Albers-Schönberg, G. 2002: Global trends in the pharmaceutical industry Puerto Rico Health Sciences Journal 21(2): 85-89
De Francisco, A.L.M. 2004: Medical doctors and pharmaceutical industry Nefrologia: Publicacion Oficial de la Sociedad Espanola Nefrologia 24(5): 393-394
Baichwal, R.S. 1988: Benefits of biotechnology to pharmaceutical industry Hindustan Antibiotics Bulletin 30(3-4): 51-53